Pharmaceutical Supply of Labetalol Hydrochloride Injection
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract entails the manufacture and supply of four units of Labetalol Hydrochloride Injection USP, 5 mg/mL in 40 mL vials, strictly adhering to FDA regulations, current Good Manufacturing Practices, and specialized military labeling standards. The product is identified by NSN 6505012579990 and is intended for use within the Department of Defense’s medical supply chain, ensuring compatibility with military pharmacopeial and logistical requirements. Production and delivery must meet all quality assurance benchmarks mandated for federal medical procurement, with full compliance documented to support inventory integration and battlefield readiness. Subcontracted under the NAICS code 325412 for Pharmaceutical Preparation Manufacturing, the solicitation was posted on July 20, 2026, with responses due by July 27, 2026. The place of performance is designated as Fort Stewart, Georgia, with a ZIP code of 31314-5185, indicating the primary logistics and distribution hub for the delivered product. The contracting entity is the Medical Supply Chain Pharm FSA under the Department of Defense, and the official request can be accessed via the DIBBS portal, underscoring the transaction’s direct alignment with military pharmaceutical procurement protocols.
General Info
Agency
NAICS
Place of Performance
FORT STEWART, GA, 31314-5185, USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
